StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Roche Holding AG
Swiss Stock Exchange:RO.SW
Sector
Location
Market Cap
USD 263.73 B
Share Price
USD 349.07
Avg Daily Volume
28,734
Change (1 day)
0.56%
Change (1 year)
13.51%
Change (YTD)
16.66%
Roche Holding AG EBT Margin for the year ending December 31, 2024: 18.90%
Roche Holding AG EBT Margin is 18.90% for the year ending December 31, 2024, a -18.86% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
-
Roche Holding AG EBT Margin for the year ending December 31, 2023 was 23.29%, a -9.94% change year over year.
-
Roche Holding AG EBT Margin for the year ending December 31, 2022 was 25.87%, a -6.64% change year over year.
-
Roche Holding AG EBT Margin for the year ending December 31, 2021 was 27.71%, a -10.06% change year over year.
-
Roche Holding AG EBT Margin for the year ending December 31, 2020 was 30.80%, a 18.20% change year over year.
Competitors
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
CSL Limited
USD 159.67
CSL.AX
+0.42
0.26%
Regeneron Pharmaceuticals, Inc.
USD 559.76
REGN
+7.18
1.30%
MERCK Kommanditgesellschaft auf Aktien
USD 133.90
MRK.DE
+3.46
2.66%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.07
0.91%
Takeda Pharmaceutical Company Limited
USD 29.72
4502.T
+0.09
0.30%
Alnylam Pharmaceuticals, Inc.
USD 322.64
ALNY
+1.77
0.55%
Key Data
| Date | EBT Margin | Operating Income Margin | Gross Profit Margin | EBIT Margin |
|---|
Competitors
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
GSK plc
USD 19.73
GSK.L
+0.37
1.92%
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
CSL Limited
USD 159.67
CSL.AX
+0.42
0.26%
Regeneron Pharmaceuticals, Inc.
USD 559.76
REGN
+7.18
1.30%
MERCK Kommanditgesellschaft auf Aktien
USD 133.90
MRK.DE
+3.46
2.66%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.07
0.91%
Takeda Pharmaceutical Company Limited
USD 29.72
4502.T
+0.09
0.30%
Alnylam Pharmaceuticals, Inc.
USD 322.64
ALNY
+1.77
0.55%